Disc Medicine, Inc.
IRON Healthcare Biotechnology
- EPS
- +2.53%
- Free cash flow
- +7.83%
- Total debt
- +106.5%
Quarter to June 2026, against a year earlier
Follow IRON
Alert me
Disc Medicine, Inc. (IRON) Shares outstanding
Disc Medicine, Inc.'s shares outstanding at the end of fiscal 2025 was $35.3M, up 27.9% from $27.6M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $38.7M. Over the past ten years it has ranged from $878.0K (fiscal 2021) to $35.3M (fiscal 2025) — the current reading is the highest in ten years. Disc Medicine, Inc. ranks 330th of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $35.3M | 27.86% |
| FY2024 | $27.6M | 23.71% |
| FY2023 | $22.3M | 2,047.82% |
| FY2022 | $1.0M | 18.34% |
| FY2021 | $878.0K | (41.91%) |
| FY2020 | $1.5M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $38.7M | 0.51% |
| Mar 2026 | $38.5M | 9.05% |
| Dec 2025 | $35.3M | 0.33% |
| Sep 2025 | $35.2M | 0.44% |
| 22 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| IOVA Iovance Biotherapeutics, Inc. compare | $450.2M |
| RLAY Relay Therapeutics, Inc. compare | $202.8M |
| ACAD ACADIA Pharmaceuticals Inc. compare | $175.5M |
| DYN Dyne Therapeutics, Inc. compare | $165.5M |
| TNGX Tango Therapeutics, Inc. compare | $149.9M |
| VKTX Viking Therapeutics, Inc. compare | $118.1M |
| XENE Xenon Pharmaceuticals Inc. compare | $99.6M |
| IRON Disc Medicine, Inc. | $38.7M |
| PBLS Parabilis Medicines, Inc. compare | $28.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item